Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.19191/EP25.1.A.860.009 | DOI Listing |
Ther Adv Respir Dis
March 2025
Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Summary● This is a plain language summary of two articles originally published in and . These articles presented the results of GALATHEA and TERRANOVA, two clinical studies that took place across 41 countries. ○ GALATHEA and TERRANOVA measured how patients' COPD changed from before their first (10, 30, or 100 mg) injection, to after 56 weeks of treatment.
View Article and Find Full Text PDFLancet Reg Health Am
March 2025
Rural Physician Leadership Program, University of Kentucky College of Medicine, Morehead, KY, USA.
Lancet Reg Health Eur
March 2025
Onco-Hematology Laboratory, Université Paris Cité, Assistance Publique - Hôpitaux de Paris, France.
Lancet Reg Health Southeast Asia
March 2025
Department of Anthropology, Fatima Jinnah Women University, The Mall, Rawalpindi, Pakistan.
Lancet Reg Health Southeast Asia
March 2025
Division of Cardiology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!